Thelior Bio: rethinking gut health from the inside out
A new spinout company, formed from research conducted at the MRC Translational Immune Discovery Unit, aims to develop a new class of therapies for patients with inflammatory bowel disease.
Read moreMRC Translational Immune Discovery Unit
Pioneering the future in the study of human immunity to uncover the molecular pathways driving immune-mediated diseases.
MRC Molecular Haematology Unit
Understanding how mature blood cells are normally made from stem cells and how this is perturbed in common blood disorders.
Centre for Computational Biology
Using computational biology to help understand complex biological systems and combat a range of human diseases.
Latest publications
-
PROM1/CD133 MARKS A PROLIFERATIVE STEM CELL LIKE POPULATION OF BLASTS IN KMT2A REARRANGED INFANT ALL.
Journal article
Cross JW. et al, (2025), Blood Adv
-
Clinical significance of preleukemic somatic GATA1 mutations in children with Down syndrome.
Journal article
Elliott N. et al, (2025), Blood
-
Ruxolitinib in Patients With Corticosteroid-Refractory or Corticosteroid-Dependent Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of the Phase III REACH3 Study.
Journal article
Zeiser R. et al, (2025), J Clin Oncol
-
Iron deficiency causes aspartate-sensitive dysfunction in CD8+ T cells.
Journal article
Teh MR. et al, (2025), Nat Commun, 16
-
Engineering antisense oligonucleotides for targeted mRNA degradation through lysosomal trafficking.
Journal article
Kashyap D. et al, (2025), Chem Sci
Upcoming Seminars
-
Tuesday, 15 July 2025, 1pm to 2pm
Speakers: Professor Bertie Gottgens
-
Wednesday, 16 July 2025, 12pm to 1pm
Speakers: Professor Fyodor Urnov
-
Tuesday, 02 September 2025, 1pm to 2pm
Speakers: Dr Arno Alpi
-
Thursday, 04 September 2025, 12pm to 1pm
Speakers: Professor Julian Downward
-
Tuesday, 30 September 2025, 1pm to 2pm
Speakers: Professor Marketa Tomkova